ES2571444T3 - Derivados de dihidrofurano-azetadina como agentes antiparasitarios - Google Patents

Derivados de dihidrofurano-azetadina como agentes antiparasitarios

Info

Publication number
ES2571444T3
ES2571444T3 ES13703286T ES13703286T ES2571444T3 ES 2571444 T3 ES2571444 T3 ES 2571444T3 ES 13703286 T ES13703286 T ES 13703286T ES 13703286 T ES13703286 T ES 13703286T ES 2571444 T3 ES2571444 T3 ES 2571444T3
Authority
ES
Spain
Prior art keywords
alkyl
cyano
haloalkyl
halo
nrarb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13703286T
Other languages
English (en)
Inventor
Nathan Anthony Logan Chubb
Valerie Vaillancourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Services LLC
Original Assignee
Zoetis Services LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47679106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2571444(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services LLC filed Critical Zoetis Services LLC
Application granted granted Critical
Publication of ES2571444T3 publication Critical patent/ES2571444T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un compuesto de fórmula (1)**Fórmula** en la que A es fenilo, naftilo o heteroarilo donde dicho heteroarilo contiene de 1 a 4 heteroátomos cada uno seleccionado independientemente de N, O y S; R1a, R1b y R1c son cada uno independientemente hidrógeno, halo, hidroxilo, ciano, nitro, alquilo C1-C6, haloalquilo C1- C6, alcoxi C1-C6, alquil C0-C3-cicloalquilo C3-C6, haloalcoxi C1-C6, -C(O)NH2, -SF5, o -S(O)pR; R2 es halo, ciano, alquilo C1-C6, haloalquilo C1-C6, nitro, hidroxilo, -C(O)NRaRb, alquenilo C2-C6, alquinilo C2-C6, - S(O)pR, u -OR; R3 es hidrógeno, halo, hidroxilo, ciano, alquilo C1-C6, haloalquilo C1-C6, alquil C0-C3-cicloalquilo C3-C6, -C(O)NH2, nitro, -SC(O)R, -C(O)NRaRb, alquil C0-C3-NRaR4, -NRaNRbR4, -NRaORb, -ONRaRb, N3, -NHR4, -OR, o -S(O)pR; R4 es hidrógeno, alquilo C1-C6, alquil C0-C6-cicloalquilo C3-C6, -C(O)R5, -C(S)R5, -C(O)NRaR5, -C(O)C(O)NRaR5, -S(O)pRc, -S(O)2NRaR5, -C(NR7)R5, -C(NR7)NRaR5, alquil C0-C6-fenilo, alquil C0-C6 heteroarilo, o alquil C0-C6- heterociclo; R5 es hidrógeno, alquilo C1-C6, alquenilo C2-C6, alquil C0-C6-cicloalquilo C3-C6, alquil C0-C6-fenilo, alquil C0-C6- heteroarilo, o alquil C0-C6-heterociclo; R6 es ciano, alquilo C1-C6, haloalquilo C1-C6, -C(O)NRaRb, alquenilo C2-C6, alquinilo C2-C6, haloalquenilo C2-C6, o haloalquinilo C2-C6; R7 es hidrógeno, alquilo C1-C6, hidroxilo, ciano, nitro, -S(O)pRc, o alcoxi C1-C6; R es alquilo C1-C6 o cicloalquilo C3-C6 cada uno opcionalmente sustituido con al menos un halo; Ra es hidrógeno, alquilo C1-C6 o alquil C0-C3-cicloalquilo C3-C6; en el que el alquilo y el alquilcicloalquilo están opcionalmente sustituidos con ciano o al menos un sustituyente halo; Rb es hidrógeno, alquilo C1-C6, cicloalquilo C3-C6, alquil C0-C3-fenilo, alquil C0-C3-heteroarilo o alquil C0-C3- heterociclo, cada uno opcionalmente sustituido, cuando sea químicamente posible, con al menos un sustituyente seleccionado de hidroxilo, ciano, halo, o -S(O)pR; Rc es alquilo C1-C6, haloalquilo C1-C6, haloalquil C1-C6-cicloalquilo C3-C6, alquil C0-C3-cicloalquilo C3-C6, alquil C0-C3- fenilo, alquil C0-C3-heteroarilo, o alquil C0-C3-heterociclo cada uno opcionalmente sustituido con al menos un sustituyente seleccionado de ciano, halo, hidroxilo, oxo, alquilo C1-C6, alcoxi C1-C6, haloalcoxi C1-C6, haloalquilo C1- C6, -S(O)pR, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)Rb, -SCN, o -C(O)NRaRb; cada uno de R4 y R5 alquilo C1-C6 o alquil C0-C6-cicloalquilo C3-C6 puede estar opcional e independientemente sustituido con al menos un sustituyente seleccionado de alquilo C1-C6, ciano, halo, hidroxilo, oxo, alquilo C1-C6, alcoxi C1-C6, haloalcoxi C1-C6, haloalquilo C1-C6, -S(O)pRc, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)Rc, -SCN, o -C(O)NRaRb; y en la que R4 y R5 alquil C0-C6-fenilo, alquil C0-C6-heteroarilo o resto alquil C0-C6-heterociclo puede estar además, opcionalmente sustituido con al menos un sustituyente seleccionado de alquilo C1-C6, hidroxialquilo C1-C6, ciano, halo, oxo, >=S, >=NR7, hidroxilo, alcoxi C1-C6, alquilo C1-C6, haloalquilo C1-C6, -SH, -S(O)pR y haloalcoxi C1-C6; n es el número entero 0, 1 o 2 y cuando n sea 2, cada uno de R2 puede ser idéntico al otro o diferente al otro y p es el número entero 0, 1 o 2; estereoisómeros del mismo y sales farmacéutica o veterinariamente aceptables del mismo.
ES13703286T 2012-02-03 2013-01-29 Derivados de dihidrofurano-azetadina como agentes antiparasitarios Active ES2571444T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261594569P 2012-02-03 2012-02-03
PCT/US2013/023662 WO2013116230A1 (en) 2012-02-03 2013-01-29 Dihydrofuran azetidine derivatives as antiparasitic agents

Publications (1)

Publication Number Publication Date
ES2571444T3 true ES2571444T3 (es) 2016-05-25

Family

ID=47679106

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13703286T Active ES2571444T3 (es) 2012-02-03 2013-01-29 Derivados de dihidrofurano-azetadina como agentes antiparasitarios

Country Status (14)

Country Link
US (1) US9133172B2 (es)
EP (1) EP2814825B1 (es)
JP (1) JP5997779B2 (es)
CN (1) CN104169273B (es)
AR (1) AR092792A1 (es)
AU (1) AU2013215368A1 (es)
BR (1) BR112014018650A8 (es)
CA (1) CA2863625C (es)
CL (1) CL2014002033A1 (es)
ES (1) ES2571444T3 (es)
MX (1) MX336430B (es)
PL (1) PL2814825T3 (es)
RU (1) RU2014131951A (es)
WO (1) WO2013116230A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX336431B (es) * 2012-05-09 2016-01-18 Zoetis Services Llc Derivados de azetidina como agentes antiparasitarios.
BR112015004826A2 (pt) * 2012-09-07 2017-07-04 Zoetis Llc derivados espirocíclicos como agentes antiparasíticos
GB2538028B (en) 2015-01-16 2017-02-08 Avista Pharma Solutions Antiparasitic compounds
AU2021311722A1 (en) 2020-07-24 2023-02-02 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW524667B (en) 1996-12-05 2003-03-21 Pfizer Parasiticidal pyrazoles
WO2005014573A1 (en) * 2003-08-07 2005-02-17 Pharmacia & Upjohn Company Llc Anthelmintic and insecticide pyrimidine derivatives
GB0329314D0 (en) 2003-12-18 2004-01-21 Pfizer Ltd Substituted arylpyrazoles
TW200538433A (en) * 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
CN101331127B (zh) * 2005-12-16 2012-05-23 杜邦公司 用于防治无脊椎害虫的5-芳基异噁唑啉
TW200803740A (en) * 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
BRPI0707091B8 (pt) 2006-03-10 2018-02-14 Nissan Chemical Ind Ltd composto de isoxalina e benzaldoxima substituído ou um sal do mesmo; pesticida, agroquímico, endo- ou ecto-parasiticidapara mamíferos ou pássaros, inseticida e acaricida contendo como um ou mais ingredientes ativos selecionados a partir do composto de isoxalina substituído e o sal do mesmo
US8372867B2 (en) * 2007-04-10 2013-02-12 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
CN101801940B (zh) 2007-09-10 2013-04-10 日产化学工业株式会社 取代异*唑啉化合物和有害生物防除剂
EP2331536B1 (en) * 2008-08-22 2013-08-21 Syngenta Participations AG Insecticidal compounds
EA201201171A1 (ru) 2010-02-22 2013-03-29 Зингента Партисипейшнс Аг Дигидрофурановые производные в качестве инсектицидных соединений
ES2682303T3 (es) * 2010-08-05 2018-09-19 Zoetis Services Llc Derivados de isoxazolina como agentes antiparasitarios

Also Published As

Publication number Publication date
PL2814825T3 (pl) 2016-08-31
CA2863625A1 (en) 2013-08-08
CN104169273A (zh) 2014-11-26
AR092792A1 (es) 2015-05-06
US9133172B2 (en) 2015-09-15
MX2014009387A (es) 2014-08-27
CN104169273B (zh) 2016-11-02
AU2013215368A1 (en) 2014-08-21
EP2814825A1 (en) 2014-12-24
BR112014018650A8 (pt) 2017-07-11
CA2863625C (en) 2016-04-26
EP2814825B1 (en) 2016-03-23
CL2014002033A1 (es) 2014-10-03
WO2013116230A1 (en) 2013-08-08
US20150038440A1 (en) 2015-02-05
BR112014018650A2 (es) 2017-06-20
JP2015511233A (ja) 2015-04-16
RU2014131951A (ru) 2016-03-27
JP5997779B2 (ja) 2016-09-28
MX336430B (es) 2016-01-18

Similar Documents

Publication Publication Date Title
AR082562A1 (es) Derivados de isoxazolina como agentes antiparasitarios
AR085649A1 (es) Derivados espirociclicos de isoxazolina como agentes antiparasitarios
CO6170061A1 (es) Compuestos de pirandiona, tiopirandiona y ciclohexantriona utiles como herbicidas, procesos para su preparacion, intermediarios utiles en su preparacion, metodos para controlar hierbas y malezas en cultivos de plantas utiles utilizando dichos herbici
AR083081A1 (es) Isoxazolin oximas como agentes antiparasitarios
ES2571444T3 (es) Derivados de dihidrofurano-azetadina como agentes antiparasitarios
CO6251271A2 (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
PE20141041A1 (es) Compuestos, metodos y formulaciones parasiticidas
AR079224A1 (es) Compuestos insecticidas basados en derivados de isoxazolina
AR086474A1 (es) Compuestos de pirazol pesticidas
CO6220907A2 (es) 4-fenil-piran-3,5-dionas, 4-fenil-tiopiran-3,5-dionas y ciclohexantrionas como nuevos herbicidas
CO6150160A2 (es) Derivados de morfolino pirimidina utiles en el tratamiento de desordenes proliferativos
CO6210770A2 (es) Compuestos 2-aril-5-heterociclil-ciclohexan-1, 3 diona y su uso como herbicidas
AR060401A1 (es) Derivados de cromen-2-ona
CO6270320A2 (es) Derivados de piperidina utiles como antagonistas del receptor orexina
AR082885A1 (es) Compuestos y composiciones para la inhibicion de nampt
AR080314A1 (es) Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa
CO5640117A2 (es) Derivados de 2,4-diamonopirimidina
PE20160608A1 (es) Compuestos de quinolina selectivamente sustituida
AR063723A1 (es) 5-oxo-5,8-dihidro-piridopirimidinas inhibidoras de c-fms quinasas, composiciones farmaceuticas que las contienen y usos como agentes anticancer, en enfermedades cardiovasculares y procesos inflamatorios
AR077292A1 (es) Derivados de piperazin - quinolin sulfonamidas y composiciones farmaceuticas
ES2422299T3 (es) Indoles (4,5-dihidro) indoles tricíclicos
CO6440540A2 (es) Nuevas pirazol-4-n-alcoxicarboxamidas como microbicidas
ES2630079T3 (es) Moduladores de la ruta del complemento y usos de los mismos
CO6220935A2 (es) Derivados de 1,2,4-triazol como moduladores de mglur5
CO6251352A2 (es) Derivados de ciclopentanodiona activos como herbicidas